Study

EORTC-22033-26033

Primary chemotherapy with temozolomide vs.radiotherapy in patients with low grade gliomas after stratification for genetic 1p loss : a phase III study

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 12-Jul-2005
Date Step1 close: 26-Mar-2010
Date Step2 close: 28-Mar-2013

Data management at EORTC

Yes

Design

Phase 3
Randomized open label

Targeted Sample size

EORTC Groups: 450 - All Groups: 700

Protocol summary

http://clinicaltrials.gov/study/NCT00182819

NCT number

NCT00182819

EudraCT

2004-002714-11

Study

EORTC-22033-26033

Primary chemotherapy with temozolomide vs.radiotherapy in patients with low grade gliomas after stratification for genetic 1p loss : a phase III study

Study documentation Back to result

Research Projects

RP-1626

Predictors of quality of life ratings from patients with primary brain tumors: the role of self-awareness and cognitive functioning